Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
33%
OVERLAP
BY WEIGHT
22
# OF OVERLAPPING
HOLDINGS
IBB
251
HOLDINGS
10%
ALSO IN PBE
PBE
27
HOLDINGS
81%
ALSO IN IBB
SECTOR DRIFT (IBB minus PBE)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in IBB |
Weight in PBE |
Overlap | |
|---|---|---|---|---|
 |
ALNYLAM PHARMACEUTICALS INC | 6.1% | 7.4% | 6.1% |
|
GILEAD SCIENCES INC | 7.4% | 5.2% | 5.2% |
|
AMGEN INC | 7.2% | 5.1% | 5.1% |
|
VERTEX PHARMACEUTICALS INC | 6.3% | 4.2% | 4.2% |
|
INCYTE CORP | 1.8% | 3.5% | 1.8% |
IBB Overweight Relative to PBE
|
REGENERON PHARMACEUTICALS | 6.6% |
|
IQVIA HOLDINGS INC | 3.5% |
 |
METTLER-TOLEDO INTERNATIONAL | 3.0% |
 |
ARGENX SE ADR | 2.7% |
|
INSMED INC | 2.5% |
|
NATERA INC | 2.3% |
|
BIOGEN IDEC INC | 2.2% |
|
GILEAD SCIENCES INC | 2.2% |
|
AMGEN INC | 2.1% |
|
VERTEX PHARMACEUTICALS INC | 2.1% |
IBB Underweight Relative to PBE
|
ROYALTY PHARMA PLC CLASS A | -5.3% |
|
ILLUMINA INC | -4.1% |
|
BIOMARIN PHARMACEUTICAL INC | -3.5% |
|
ANAVEX LIFE SCIENCES CORP. | -3.4% |
|
COLLEGIUM PHARMACEUTICAL, INC. | -3.3% |
|
UNITED THERAPEUTICS CORP | -3.3% |
|
ARROWHEAD PHARMACEUTICALS, INC. | -3.2% |
|
AMICUS THERAPEUTICS INC | -2.8% |
|
PROTAGONIST THERAPEUTICS, INC. | -2.8% |
|
DYNAVAX TECHNOLOGIES CORP | -2.7% |